ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 53 filers reported holding ODONATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $203,000 | -43.0% | 10,565 | +26.7% | 0.00% | – |
| Q2 2020 | $356,000 | +64.1% | 8,341 | +6.0% | 0.00% | – |
| Q1 2020 | $217,000 | -12.9% | 7,868 | +2.6% | 0.00% | – |
| Q4 2019 | $249,000 | +15.8% | 7,669 | +31.1% | 0.00% | – |
| Q2 2019 | $215,000 | +1164.7% | 5,848 | +655.6% | 0.00% | – |
| Q2 2018 | $17,000 | -86.7% | 774 | -87.2% | 0.00% | – |
| Q1 2018 | $128,000 | – | 6,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $53,060,000 | 14.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $1,710,000 | 0.93% |
| Boxer Capital, LLC | 5,607,086 | $19,176,000 | 0.65% |
| Samsara BioCapital, LLC | 700,421 | $2,395,000 | 0.44% |
| SABBY MANAGEMENT, LLC | 634,728 | $2,171,000 | 0.42% |
| Prosight Management, LP | 117,621 | $402,000 | 0.33% |
| QCM Cayman, Ltd. | 15,478 | $53,000 | 0.16% |
| Ikarian Capital, LLC | 1,336,412 | $4,571,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 169,198 | $579,000 | 0.13% |
| Walleye Capital LLC | 273,000 | $934,000 | 0.05% |